QIAGEN serves more than 500,000 customers around the globe, all seeking insights from the building blocks of life – DNA, RNA and proteins. We deliver Sample to Insight solutions for molecular testing, propelling QIAGEN customers from start to finish to unlock new insights. This is how we make improvements in life possible.
Doctors look to our solutions to diagnose diseases and gain precise insights for better treatment decisions. Researchers rely on our cutting-edge expertise to conquer scientific frontiers and translate genomic insights into new medicines. Forensic investigators, veterinarians and food safety labs depend on our applied technologies.
Our product portfolio spans the full range of molecular testing applications. We lead the world in products to extract, purify and stabilize DNA, RNA and protein from biological samples, even the most difficult, a critical first step in each customer’s quest to generate new insights. Our novel testing technologies can target single molecular variants – or hundreds. QIAGEN software analyzes and interprets vast amounts of data to deliver valuable insights. Our automation systems bring together all of these steps in seamless end-to-end workflows
We call our strategic framework Sample to Insight. QIAGEN offers advanced molecular testing solutions that move customers through the whole process – faster, better and more efficiently. We identify bottlenecks, solve problems and exceed expectations. It’s who we are.
Our journey began in the mid-1980s, the early days of biotechnology. As an entrepreneurial spin-off of university research, QIAGEN created a simpler, safer way for laboratories to handle the painstaking tasks of preparing samples to explore the mysteries of DNA. Since then, we have expanded across the continuum of molecular testing to establish QIAGEN as a global leader in rapidly growing fields of molecular diagnostics and life sciences.
Today some 4,700 QIAGEN employees, based in more than 25 countries, provide expertise and service to customers nearly everywhere. Our people share a collaborative, truly global culture – plus a commitment to making improvements in life possible.
As a public company listed on the New York Stock and Frankfurt Prime Standard exchanges, QIAGEN embraces transparency, accountability and good corporate governance.